Breaking News

Velesco Pharma Gets Clinical Supply Contract

Will develop and manufacture clinical supplies for a new treatment for beta-thalassemia

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Velesco Pharmaceutical Services has been awarded a subcontract for analytical method development, manufacturing clinical supplies, and testing the stability of an investigational drug for the treatment for beta-thalassemia, a blood disorder that reduces the production of proteins that carry oxygen to cells throughout the body. The subcontract award of $350,000 is funded by the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS) through its Therap...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters